Search Results

Terazosin HCl 250mg  | ≥99%

CSNpharm

Terazosin HCl is a selective antagonist for alpha-adrenergic receptor, used for treatment for hypertension and prostate enlargement (BPH) through lowering the blood pressure with elimination half-life of ‎12 hours.

More Information Supplier Page

Terazosin HCl 100mg  | ≥99%

CSNpharm

Terazosin HCl is a selective antagonist for alpha-adrenergic receptor, used for treatment for hypertension and prostate enlargement (BPH) through lowering the blood pressure with elimination half-life of ‎12 hours.

More Information Supplier Page

BGP-15 5mg  | ≥99%

CSNpharm

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

More Information Supplier Page

BGP-15 50mg  | ≥99%

CSNpharm

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

More Information Supplier Page

Dehydroevodiamine 1g  | ≥99%

CSNpharm

Dehydroevodiamine is an alkaloid isolated from E. rutaecarpa and possesses anti-inflammatory, antiarrhythmic, hypotensive, and anti-amnesic biological activities.

More Information Supplier Page

Fenofibrate 5g  | ≥99%

CSNpharm

Fenofibrate is an agonist of PPARα (EC50 = 30 μM) and an inhibitor of CYP2C19 (IC50 = 0.2 μM) and CYP2B6 (IC50 = 0.7 μM). Fenofibrate is a fibric acid derivative and used to treat hypercholesterolemia and hypertriglyceridemia.

More Information Supplier Page

Fenofibrate 250mg  | ≥99%

CSNpharm

Fenofibrate is an agonist of PPARα (EC50 = 30 μM) and an inhibitor of CYP2C19 (IC50 = 0.2 μM) and CYP2B6 (IC50 = 0.7 μM). Fenofibrate is a fibric acid derivative and used to treat hypercholesterolemia and hypertriglyceridemia.

More Information Supplier Page